Health status in the TORCH study of COPD: treatment efficacy and other determinants of change

Paul W Jones; Julie A Anderson; Peter Ma Calverley; Bartolome R Celli; Gary T Ferguson; Christine Jenkins; Julie C Yates; Jørgen Vestbo; Michael D Spencer; TORCH investigators

doi:10.1186/1465-9921-12-71

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change

Paul W Jones, Julie A Anderson, Peter Ma Calverley, Bartolome R Celli, Gary T Ferguson, Christine Jenkins, Julie C Yates, Jørgen Vestbo, Michael D Spencer, TORCH investigators

58 Citations (Scopus)

Abstract

Little is known about factors that determine health status decline in clinical trials of COPD.

Original language	English
Journal	Respiratory Research
Volume	12
Issue number	71
ISSN	1465-9921
DOIs	https://doi.org/10.1186/1465-9921-12-71
Publication status	Published - 2011

Keywords

Adrenergic beta-2 Receptor Agonists
Age Factors
Aged
Albuterol
Androstadienes
Asia
Bronchodilator Agents
Disease Progression
Double-Blind Method
Drug Combinations
Europe
Female
Forced Expiratory Volume
Glucocorticoids
Health Status
Health Status Indicators
Humans
Lung
Male
Middle Aged
Predictive Value of Tests
Pulmonary Disease, Chronic Obstructive
Quality of Life
Questionnaires
Risk Assessment
Risk Factors
Severity of Illness Index
Time Factors
Treatment Outcome
United States

Access to Document

10.1186/1465-9921-12-71

Cite this

@article{6b8a0a0128ff46a5ab8e0b440746885e,

title = "Health status in the TORCH study of COPD: treatment efficacy and other determinants of change",

abstract = "Little is known about factors that determine health status decline in clinical trials of COPD.",

keywords = "Adrenergic beta-2 Receptor Agonists, Age Factors, Aged, Albuterol, Androstadienes, Asia, Bronchodilator Agents, Disease Progression, Double-Blind Method, Drug Combinations, Europe, Female, Forced Expiratory Volume, Glucocorticoids, Health Status, Health Status Indicators, Humans, Lung, Male, Middle Aged, Predictive Value of Tests, Pulmonary Disease, Chronic Obstructive, Quality of Life, Questionnaires, Risk Assessment, Risk Factors, Severity of Illness Index, Time Factors, Treatment Outcome, United States",

author = "Jones, {Paul W} and Anderson, {Julie A} and Calverley, {Peter Ma} and Celli, {Bartolome R} and Ferguson, {Gary T} and Christine Jenkins and Yates, {Julie C} and J{\o}rgen Vestbo and Spencer, {Michael D} and {TORCH investigators}",

year = "2011",

doi = "10.1186/1465-9921-12-71",

language = "English",

volume = "12",

journal = "Respiratory Research",

issn = "1465-9921",

publisher = "BioMed Central Ltd",

number = "71",

}

TY - JOUR

T1 - Health status in the TORCH study of COPD

T2 - treatment efficacy and other determinants of change

AU - Jones, Paul W

AU - Anderson, Julie A

AU - Calverley, Peter Ma

AU - Celli, Bartolome R

AU - Ferguson, Gary T

AU - Jenkins, Christine

AU - Yates, Julie C

AU - Vestbo, Jørgen

AU - Spencer, Michael D

AU - TORCH investigators

PY - 2011

Y1 - 2011

N2 - Little is known about factors that determine health status decline in clinical trials of COPD.

AB - Little is known about factors that determine health status decline in clinical trials of COPD.

KW - Adrenergic beta-2 Receptor Agonists

KW - Age Factors

KW - Aged

KW - Albuterol

KW - Androstadienes

KW - Asia

KW - Bronchodilator Agents

KW - Disease Progression

KW - Double-Blind Method

KW - Drug Combinations

KW - Europe

KW - Female

KW - Forced Expiratory Volume

KW - Glucocorticoids

KW - Health Status

KW - Health Status Indicators

KW - Humans

KW - Lung

KW - Male

KW - Middle Aged

KW - Predictive Value of Tests

KW - Pulmonary Disease, Chronic Obstructive

KW - Quality of Life

KW - Questionnaires

KW - Risk Assessment

KW - Risk Factors

KW - Severity of Illness Index

KW - Time Factors

KW - Treatment Outcome

KW - United States

U2 - 10.1186/1465-9921-12-71

DO - 10.1186/1465-9921-12-71

M3 - Journal article

C2 - 21627828

VL - 12

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

IS - 71

ER -

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change

Abstract

Keywords

Access to Document

Fingerprint

Cite this